Aligos Therapeutics Announces Research Collaboration and Development Agreement with Xiamen Amoytop Biotech Co. Ltd. for Use of Aligos' Oligonucleotide Platform for the Treatment of Liver Diseases

SOUTH SAN FRANCISCO, Calif., May 12, 2023 -- Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver... | May 12, 2023

Related Keywords

China ,Chinese ,Sun Li ,Corey Davis ,Amy Jobe ,Lawrence Blatt ,Xiamen Amoytop Biotech Co ,Aligos Therapeutics Inc ,Lifesci Communications ,Nasdaq ,Exchange Commission ,Exchange Commission On ,Xiamen Amoytop Biotech ,Greater China ,Securities Litigation Reform Act ,Aligo Quarterly Report ,Aligos Therapeutics ,Nc Stock Exchange ,News ,Information ,Press Release ,Mouth ,Han ,Bay ,023 ,Aligos ,Linical ,Stage ,Iopharmaceutical ,Company ,Ocused ,N ,Developing ,Novel ,Herapeutics ,O ,Address ,Unmet ,Medical ,Needs ,N Algs Us01626l1052 ,